HIV-1 assembly and budding as targets for drug discovery

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Abstract

Research conducted during the past several years has led to an increased understanding of the roles played by the viral protein Gag and specific cellular factors in HIV assembly/budding. The identification of compounds that interfere with this process validates this late step in virus replication as a target for HIV therapeutic discovery. In this review, current understanding of HIV-1 assembly/budding is described and several developmental stage drugs that target this process are reviewed.

Original languageEnglish
Pages (from-to)148-154
Number of pages7
JournalCurrent Opinion in Investigational Drugs
Volume6
Issue number2
StatePublished - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Assembly
  • Budding
  • Drug
  • HIV-1
  • Target

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'HIV-1 assembly and budding as targets for drug discovery'. Together they form a unique fingerprint.

Cite this